Evidence map›Paper›PMID 36626229›Full record

ArticleJCI insight2023

Low nephron endowment increases susceptibility to renal stress and chronic kidney disease.

Pamela I Good, Ling Li, Holly A Hurst, Ileana Serrano Herrera, Katherine Xu, Meenakshi Rao, David A Bateman, Qais Al-Awqati, Vivette D D'Agati, Frank Costantini and 1 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
18.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Developmental origins of hypertension and renal injury: epigenetic memory in renal stem and progenitor cells.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Pamela I GoodDepartment of Pediatrics and.
Ling LiDepartment of Pediatrics and.
Holly A HurstDepartment of Pediatrics and.
Ileana Serrano HerreraDepartment of Pediatrics and.
Katherine XuDepartment of Internal Medicine, Columbia University Vagelos College of Physicians and Surgeons New York, New York, USA.
Meenakshi RaoDepartment of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston Massachusetts, USA.
David A BatemanDepartment of Pediatrics and.
Qais Al-AwqatiDepartment of Internal Medicine, Columbia University Vagelos College of Physicians and Surgeons New York, New York, USA.
Vivette D D'AgatiDepartment of Pathology and Cellular Biology at Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Frank CostantiniDepartment of Genetics and Development at Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Fangming LinDepartment of Pediatrics and.
Columbia University · USBoston Children's Hospital · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
Renal Physiology and Phenotyping CoreP30DK079310 · NIDDK · YALE UNIVERSITY · PI PREISIG, PATRICIA A · 2008 to 2022
$16.8M
Generation of New Mouse Models of Low Nephron Numbers to Understand Pathogenesis of AKI and CKD in Humans Born PretermR01DK118140 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LIN, FANGMING · 2019 to 2022
$1.7M
NCI NIH HHS P30 CA013696NICHD NIH HHS K12 HD000850NIDDK NIH HHS P30 DK079310NIDDK NIH HHS R01 DK118140
6 · The paper itself

Abstract

Preterm birth results in low nephron endowment and increased risk of acute kidney injury (AKI) and chronic kidney disease (CKD). To understand the pathogenesis of AKI and CKD in preterm humans, we generated potentially novel mouse models with a 30%-70% reduction in nephron number by inhibiting or deleting Ret tyrosine kinase in the developing ureteric bud. These mice developed glomerular and tubular hypertrophy, followed by the transition to CKD, recapitulating the renal pathological changes seen in humans born preterm. We injected neonatal mice with gentamicin, a ubiquitous nephrotoxic exposure in preterm infants, and detected more severe proximal tubular injury in mice with low nephron number compared with controls with normal nephron number. Mice with low nephron number had reduced proliferative repair with more rapid development of CKD. Furthermore, mice had more profound inflammation with highly elevated levels of MCP-1 and CXCL10, produced in part by damaged proximal tubules. Our study directly links low nephron endowment with postnatal renal hypertrophy, which in this model is maladaptive and results in CKD. Underdeveloped kidneys are more susceptible to gentamicin-induced AKI, suggesting that AKI in the setting of low nephron number is more severe and further increases the risk of CKD in this vulnerable population.

Indexed as

Acute Kidney InjuryPremature BirthRenal Insufficiency, ChronicAnimalsFemaleGentamicinsHumansHypertrophyInfant, PrematureKidneyMiceNephronsGentamicinsChronic kidney diseaseNephrology

Identifiers

PMID36626229
PMCPMC9977438
OpenAlexW4315436615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.